13F reference period
Q3 2026
CUSIP: G8708J109
13F reference period
Q3 2026
Institutions Reporting
32
Shares (Excl. Options)
Price
$12.51
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 32 institutions filings for Q3 2026.
Security key
G8708J109
13F reference period
Q3 2026
13F holders
32
13D/G owners
5
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP G8708J109:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TCGX Sponsor, LLC | 22% | $25,225,200 | 2,502,500 | TCGX Sponsor, LLC | 30 Sep 2026 | |||
| ADAR1 Capital Management, LLC | 5.5% | $5,043,770 | 500,374 | ADAR1 Capital Management, LLC | 30 Sep 2026 | |||
| BIOTECHNOLOGY VALUE FUND L P | 5.5% | 500,000 | BVF PARTNERS L P/IL | 05 Aug 2026 | ||||
| RA CAPITAL MANAGEMENT, L.P. | 5.5% | 500,000 | RA Capital Management, L.P. | 06 Aug 2026 | ||||
| Sirenia Capital Management LP | 5.5% | $6,265,000 | 500,000 | Sirenia Capital Management LP | 30 Sep 2026 |
13F concentration
Largest 13F positions for this security by reported shares and value.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BVF INC/IL | 5.5% | 500,000 | 0.21% | $6,255,000 | |
| Janus Henderson Group Ltd. | 5.5% | 500,000 | 0% | $6,437,500 | |
| RA CAPITAL MANAGEMENT, L.P. | 5.5% | 500,000 | 0.06% | $6,255,000 | |
| Nantahala Capital Management, LLC | 4.5% | 412,990 | 0.29% | $5,166,505 | |
| Squadron Capital Management LLC | 4.1% | 370,220 | 1.4% | $4,631,452 | |
| Woodline Partners LP | 3.3% | 300,210 | 0.01% | $3,755,627 | |
| EVENTIDE ASSET MANAGEMENT, LLC | 3.3% | 300,000 | 0.05% | $3,753,000 | |
| Spruce Street Capital LP | 3.3% | 300,000 | 0.6% | $3,753,000 | |
| Deep Track Capital, LP | 3.3% | 300,000 | 0.06% | $3,753,000 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.3% | 300,000 | 0.01% | $3,753,000 | |
| Paradigm Biocapital Advisors LP | 3.3% | 300,000 | 0.07% | $3,753,000 | |
| Frazier Life Sciences Management, L.P. | 3.3% | 300,000 | 0.09% | $3,753,000 | |
| Commodore Capital LP | 3.3% | 300,000 | 0.29% | $3,753,000 | |
| Venrock Adviser, LLC | 3.3% | 300,000 | 0.18% | $3,753,000 | |
| Redmile Group, LLC | 3.3% | 299,860 | 0.27% | $3,751,249 | |
| Trails Edge Capital Partners, LP | 2.7% | 250,000 | 0.45% | $3,127,500 | |
| EcoR1 Capital, LLC | 2.7% | 250,000 | 0.15% | $3,127,500 | |
| Soleus Capital Management, L.P. | 2.5% | 225,000 | 0.1% | $2,814,750 | |
| Affinity Asset Advisors, LLC | 2.2% | 200,000 | 0.14% | $2,502,000 | |
| Caligan Partners LP | 2.2% | 200,000 | 0.15% | $2,502,000 | |
| Logos Global Management LP | 2.2% | 200,000 | 0.15% | $2,502,000 | |
| STEMPOINT CAPITAL LP | 1.1% | 100,000 | 0.22% | $1,251,000 | |
| Seven Fleet Capital Management LP | 1.1% | 100,000 | 0.24% | $1,251,000 | |
| SAMSARA BIOCAPITAL, LLC | 1.1% | 100,000 | 0.12% | $1,251,000 | |
| MOORE CAPITAL MANAGEMENT, LP | 0.83% | 75,744 | 0.03% | $947,557 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 7,550,398 | $94,637,979 | +$92,112,573 | $12.51 | 32 |